AR057932A1 - Comprimido bicapa que comprende telmisartan y diuretico - Google Patents
Comprimido bicapa que comprende telmisartan y diureticoInfo
- Publication number
- AR057932A1 AR057932A1 ARP060105184A ARP060105184A AR057932A1 AR 057932 A1 AR057932 A1 AR 057932A1 AR P060105184 A ARP060105184 A AR P060105184A AR P060105184 A ARP060105184 A AR P060105184A AR 057932 A1 AR057932 A1 AR 057932A1
- Authority
- AR
- Argentina
- Prior art keywords
- diuretico
- bicype
- compressed
- telmisartan
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Un comprimido farmacéutico bicapa que comprende una primera capa que contiene 3 a 50% en peso de telmisartan dispersado en una matriz del comprimido disolvente y una segunda capa que contiene un diurético en una matriz del comprimido desintegrante, así como un procedimiento para producir el mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05025601 | 2005-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057932A1 true AR057932A1 (es) | 2007-12-26 |
Family
ID=38067569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105184A Withdrawn AR057932A1 (es) | 2005-11-24 | 2006-11-24 | Comprimido bicapa que comprende telmisartan y diuretico |
Country Status (7)
Country | Link |
---|---|
US (1) | US8637078B2 (es) |
EP (1) | EP1959934A2 (es) |
JP (2) | JP2009517366A (es) |
AR (1) | AR057932A1 (es) |
CA (1) | CA2625404C (es) |
TW (1) | TW200806288A (es) |
WO (1) | WO2007060170A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8115011B2 (en) | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
EP2203158A4 (en) | 2007-10-30 | 2012-12-26 | Reddys Lab Ltd Dr | PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE |
CA2715350C (en) | 2008-03-19 | 2017-02-14 | Ratiopharm Gmbh | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
WO2009135646A2 (en) | 2008-05-05 | 2009-11-12 | Farmaprojects, Sa | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
CZ301299B6 (cs) | 2008-11-24 | 2010-01-06 | Zentiva, A.S. | Pevná farmaceutická kompozice s úcinnými látkami atorvastatinem a telmisartanem |
ES2415357T3 (es) | 2009-06-19 | 2013-07-25 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procedimiento para la preparación de telmisartán |
TR200906506A2 (tr) | 2009-08-24 | 2011-03-21 | Bi̇lgi̇ç Mahmut | Telmisartan içeren katı dozaj formları. |
JP2011136908A (ja) * | 2009-12-25 | 2011-07-14 | Kyowa Yakuhin Kogyo Kk | アンギオテンシンii受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンii受容体拮抗剤の保存安定性向上方法 |
WO2011161123A2 (en) | 2010-06-21 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Multilayer pharmaceutical tablet comprising telmisartan and a diuretic |
WO2013172297A1 (ja) * | 2012-05-14 | 2013-11-21 | 塩野義製薬株式会社 | 6,7-不飽和-7-カルバモイルモルヒナン誘導体含有製剤 |
JP6018420B2 (ja) * | 2012-06-05 | 2016-11-02 | ニプロ株式会社 | アンジオテンシンii受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物 |
WO2014119767A1 (ja) | 2013-01-31 | 2014-08-07 | 沢井製薬株式会社 | テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤 |
JP6218664B2 (ja) * | 2013-04-04 | 2017-10-25 | 沢井製薬株式会社 | テルミサルタン含有錠剤 |
CN108524460B (zh) * | 2018-05-14 | 2021-01-01 | 佛山市南海东方澳龙制药有限公司 | 烯啶虫胺双层片 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6263520A (ja) * | 1985-09-14 | 1987-03-20 | Kyorin Pharmaceut Co Ltd | 抗リウマチ剤 |
TW235239B (es) | 1992-11-20 | 1994-12-01 | Pfizer | |
AU676315B2 (en) * | 1993-06-30 | 1997-03-06 | Takeda Chemical Industries Ltd. | Stabilized solid pharmaceutical preparation and method of producing the same |
JP3220373B2 (ja) * | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | 持続性ニフエジピン製剤 |
JPH1053520A (ja) * | 1996-06-03 | 1998-02-24 | Takeda Chem Ind Ltd | 抗疲労剤 |
US5906852A (en) * | 1997-11-04 | 1999-05-25 | Nabisco, Inc. | Surface-modified cellulose as low calorie flour replacements |
WO2000027397A1 (en) | 1998-11-06 | 2000-05-18 | Glaxo Group Limited | Antihypertensive medicaments containing lacidipine and telmisartan |
FR2787330A1 (fr) | 1998-12-18 | 2000-06-23 | Sanofi Sa | Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe |
DE19901921C2 (de) | 1999-01-19 | 2001-01-04 | Boehringer Ingelheim Pharma | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
EP1054019A1 (en) * | 1999-05-18 | 2000-11-22 | Shin-Etsu Chemical Co., Ltd. | Low-substituted hydroxypropyl cellulose |
KR20030097892A (ko) * | 2001-05-25 | 2003-12-31 | 에스에스 세야쿠 가부시키 가이샤 | 의약 배합제 |
PT2260833E (pt) * | 2002-01-16 | 2012-12-26 | Boehringer Ingelheim Pharma | Comprimido farmacêutico de duas camadas compreendendo telmisartan e um diurético |
US20040028505A1 (en) | 2002-06-07 | 2004-02-12 | Bilbrey Robert A. | Document tape binding system with automatic tape feed, tape indicia sensing, spine printing method and post-bind automation mechanisms |
US8980870B2 (en) * | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
DE10319450A1 (de) | 2003-04-30 | 2004-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung des Telmisartan Natriumsalzes |
CA2532450C (en) | 2003-07-16 | 2012-09-11 | Boehringer Ingelheim International Gmbh | Chlorthalidone combinations |
DE102004008804A1 (de) * | 2004-02-20 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mehrschichttablette |
WO2006063737A1 (en) | 2004-12-17 | 2006-06-22 | Boehringer Ingelheim International Gmbh | Combination therapy comprising telmisartan and hydrochlorothiazide |
WO2007061415A1 (en) * | 2005-11-22 | 2007-05-31 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions of telmisartan |
-
2006
- 2006-11-15 US US11/560,059 patent/US8637078B2/en active Active
- 2006-11-22 CA CA2625404A patent/CA2625404C/en not_active Expired - Fee Related
- 2006-11-22 JP JP2008541736A patent/JP2009517366A/ja active Pending
- 2006-11-22 WO PCT/EP2006/068737 patent/WO2007060170A2/en active Application Filing
- 2006-11-22 EP EP06819653A patent/EP1959934A2/en not_active Withdrawn
- 2006-11-23 TW TW095143437A patent/TW200806288A/zh unknown
- 2006-11-24 AR ARP060105184A patent/AR057932A1/es not_active Withdrawn
-
2013
- 2013-02-08 JP JP2013023562A patent/JP5833037B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
WO2007060170A3 (en) | 2007-09-13 |
TW200806288A (en) | 2008-02-01 |
JP5833037B2 (ja) | 2015-12-16 |
CA2625404A1 (en) | 2007-05-31 |
CA2625404C (en) | 2015-10-06 |
JP2009517366A (ja) | 2009-04-30 |
JP2013082754A (ja) | 2013-05-09 |
US20080113023A1 (en) | 2008-05-15 |
US8637078B2 (en) | 2014-01-28 |
EP1959934A2 (en) | 2008-08-27 |
WO2007060170A2 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057932A1 (es) | Comprimido bicapa que comprende telmisartan y diuretico | |
ECSP099320A (es) | Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos | |
CR20110186A (es) | Formulación farmacéutica 514 | |
CL2013001104A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt2 y una insulina; y uso para tratar una enfermedad o afeccion tal como diabetes mellitus, diabetes mellitus tipo 1 y 2, entre otras. | |
CL2012000793A1 (es) | Composicion farmaceutica que comprende 1-cloro-4-(3-d-glucopiranos-il)-2-[4-((s)-tetrahidrofuran-3-iloxi)-bencil]benceno, clorhidrato de metformina y uno o mas excipientes farmaceuticos. | |
SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
UY29300A1 (es) | Compuestos quimicos | |
CL2008000733A1 (es) | Composicion farmaceutica que comprende un comprimido o capa de comprimido que comprende a telmisartan en forma amorfa, un agente basico y sorbitol; metodo para la preparacion de dicho comprimido; y su uso para tratar diabetes, dislipidemia, entre otr | |
BR112013008180A2 (pt) | materiais compósitos incluindo nanopartículas, ferramentas de sondagem da terra e componentes incluindo tais materiais compósitos, materiais policristalinos incluindo nanopartículas, e métodos relacionados | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
CL2008002486A1 (es) | Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes. | |
AR098417A1 (es) | Formulación farmacéutica combinada que comprende amlodipina, losartán y rosuvastatina | |
ES2531516T3 (es) | Uso de escina | |
ECSP088569A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y uso de los mismos para el tratamiento de enfermedades cardiovasculares | |
CR11133A (es) | Composicion biofertilizante | |
ES2660019T3 (es) | Parche que contiene diclofenaco y tiocolchicósido | |
UY31383A1 (es) | N-aroil-n??-(6-(opcionalmente sustituido) alquilsulfonibenzotiazol-2-il)ureas | |
AR107858A1 (es) | Placa de yeso y un proceso para la fabricación | |
PA8824601A1 (es) | Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia | |
CR20110285A (es) | Extrudidos con sustancias activas con forma de agujas | |
UY31887A (es) | Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión | |
AR053144A1 (es) | Composicion farmaceutica solida que comprende telitromicina | |
AR062626A1 (es) | Comprimidos de polimero de poliestireno sulfonato, su preparacion y uso | |
PA8616101A1 (es) | Forma de presentacion del naproxeno sodico | |
ES2652253T3 (es) | Preparación de vitamina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |